Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Oct 26;83(10):1344–1350. doi: 10.1054/bjoc.2000.1462

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer

A G Renehan 1, J Jones 2, C S Potten 3, S M Shalet 4, S T O'Dwyer 1
PMCID: PMC2408787  PMID: 11044360

Abstract

This study explored the relationships of serum insulin-like growth factors, IGF-I and IGF-II, and their binding proteins (IGFBP)-2 and IGFBP-3, with key clinicopathological parameters in 92 patients with colorectal cancer (cases). Comparisons were made with 57 individuals who had a normal colonoscopy (controls). Serial changes were examined in 27 cases. As IGF-related peptides are age- and sex-dependent, absolute concentrations were converted to standard deviation scores (SDS). Mean IGF-II SDS were elevated in Dukes A (n= 12 P< 0.001) and Dukes B (n= 25 P< 0.001) cases compared with controls, but not in advanced disease. Compared with controls, mean IGFBP-2 SDS were significantly elevated in patients with Dukes B (P< 0.001), Dukes C (n= 13 P< 0.001) and advanced disease (n= 42 P< 0.0001), with a significant trend from early to advanced disease (one-way ANOVA P< 0.001). Furthermore, IGFBP-2 SDS were positively related to tumour size (P= 0.01) and fell significantly in patients following curative resection (P= 0.04), suggesting that circulating levels reflect tumour load. We tested the potential tumour marker characteristics of IGFBP-2 SDS against three endpoints: metastasis alone; local pelvic recurrence alone; and metastasis and recurrence combined. The sensitivities for IGFBP-2 alone (≥ + 2SD) were modest at 55%, 46%, and 52%, but in combination with CEA, increased substantially to 90%, 77% and 86%, respectively. We conclude that the serum IGF-II and IGFBP-2 profiles may provide insights into underlying biological mechanisms, and that serum IGFBP-2 may have an adjunct role in cancer surveillance in patients with colorectal cancer. © 2000 Cancer Research Campaign

Keywords: IGF-II, binding proteins, colorectal cancer

Full Text

The Full Text of this article is available as a PDF (94.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adenis A., Peyrat J. P., Hecquet B., Delobelle A., Depadt G., Quandalle P., Bonneterre J., Demaille A. Type I insulin-like growth factor receptors in human colorectal cancer. Eur J Cancer. 1995;31A(1):50–55. doi: 10.1016/0959-8049(94)00368-f. [DOI] [PubMed] [Google Scholar]
  2. Arai T., Busby W., Jr, Clemmons D. R. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology. 1996 Nov;137(11):4571–4575. doi: 10.1210/endo.137.11.8895319. [DOI] [PubMed] [Google Scholar]
  3. Baciuchka M., Remacle-Bonnet M., Garrouste F., Favre R., Sastre B., Pommier G. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor. Int J Cancer. 1998 Oct 23;79(5):460–467. doi: 10.1002/(sici)1097-0215(19981023)79:5<460::aid-ijc3>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  4. Chan J. M., Stampfer M. J., Giovannucci E., Gann P. H., Ma J., Wilkinson P., Hennekens C. H., Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998 Jan 23;279(5350):563–566. doi: 10.1126/science.279.5350.563. [DOI] [PubMed] [Google Scholar]
  5. Clemmons D. R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 1997 Mar;8(1):45–62. doi: 10.1016/s1359-6101(96)00053-6. [DOI] [PubMed] [Google Scholar]
  6. Cohen P., Peehl D. M., Stamey T. A., Wilson K. F., Clemmons D. R., Rosenfeld R. G. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 1993 Apr;76(4):1031–1035. doi: 10.1210/jcem.76.4.7682560. [DOI] [PubMed] [Google Scholar]
  7. Freier S., Weiss O., Eran M., Flyvbjerg A., Dahan R., Nephesh I., Safra T., Shiloni E., Raz I. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut. 1999 May;44(5):704–708. doi: 10.1136/gut.44.5.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gockerman A., Clemmons D. R. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ Res. 1995 Apr;76(4):514–521. doi: 10.1161/01.res.76.4.514. [DOI] [PubMed] [Google Scholar]
  9. Hammerlid E., Wirblad B., Sandin C., Mercke C., Edström S., Kaasa S., Sullivan M., Westin T. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck. 1998 Sep;20(6):540–548. doi: 10.1002/(sici)1097-0347(199809)20:6<540::aid-hed9>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  10. Hankinson S. E., Willett W. C., Colditz G. A., Hunter D. J., Michaud D. S., Deroo B., Rosner B., Speizer F. E., Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998 May 9;351(9113):1393–1396. doi: 10.1016/S0140-6736(97)10384-1. [DOI] [PubMed] [Google Scholar]
  11. Ho P. J., Baxter R. C. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) 1997 Mar;46(3):333–342. [PubMed] [Google Scholar]
  12. Hoeflich A., Fettscher O., Lahm H., Blum W. F., Kolb H. J., Engelhardt D., Wolf E., Weber M. M. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res. 2000 Feb 15;60(4):834–838. [PubMed] [Google Scholar]
  13. Höflich A., Lahm H., Blum W., Kolb H., Wolf E. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Lett. 1998 Sep 4;434(3):329–334. doi: 10.1016/s0014-5793(98)01011-4. [DOI] [PubMed] [Google Scholar]
  14. Juul A., Main K., Blum W. F., Lindholm J., Ranke M. B., Skakkebaek N. E. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994 Jul;41(1):85–93. doi: 10.1111/j.1365-2265.1994.tb03788.x. [DOI] [PubMed] [Google Scholar]
  15. Kanety H., Kattan M., Goldberg I., Kopolovic J., Ravia J., Menczer J., Karasik A. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. Br J Cancer. 1996 May;73(9):1069–1073. doi: 10.1038/bjc.1996.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kawamoto K., Onodera H., Kondo S., Kan S., Ikeuchi D., Maetani S., Imamura M. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology. 1998 May-Jun;55(3):242–248. doi: 10.1159/000011858. [DOI] [PubMed] [Google Scholar]
  17. Lahm H., Amstad P., Wyniger J., Yilmaz A., Fischer J. R., Schreyer M., Givel J. C. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer. 1994 Aug 1;58(3):452–459. doi: 10.1002/ijc.2910580325. [DOI] [PubMed] [Google Scholar]
  18. Lambert S., Carlisi A., Collette J., Franchimont P., Gol-Winkler R. Insulin-like growth factor II in two human colon-carcinoma cell lines: gene structure and expression, and protein secretion. Int J Cancer. 1992 Sep 30;52(3):404–408. doi: 10.1002/ijc.2910520313. [DOI] [PubMed] [Google Scholar]
  19. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med. 1997 Feb 27;336(9):633–640. doi: 10.1056/NEJM199702273360907. [DOI] [PubMed] [Google Scholar]
  20. Ma J., Pollak M. N., Giovannucci E., Chan J. M., Tao Y., Hennekens C. H., Stampfer M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999 Apr 7;91(7):620–625. doi: 10.1093/jnci/91.7.620. [DOI] [PubMed] [Google Scholar]
  21. Macaulay V. M. Insulin-like growth factors and cancer. Br J Cancer. 1992 Mar;65(3):311–320. doi: 10.1038/bjc.1992.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Manousos O., Souglakos J., Bosetti C., Tzonou A., Chatzidakis V., Trichopoulos D., Adami H. O., Mantzoros C. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer. 1999 Sep 24;83(1):15–17. doi: 10.1002/(sici)1097-0215(19990924)83:1<15::aid-ijc4>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  23. Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993 Aug 25;270(8):943–947. [PubMed] [Google Scholar]
  24. Mohnike K. L., Kluba U., Mittler U., Aumann V., Vorwerk P., Blum W. F. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr. 1996 Feb;155(2):81–86. doi: 10.1007/BF02075755. [DOI] [PubMed] [Google Scholar]
  25. Müller H. L., Oh Y., Lehrnbecher T., Blum W. F., Rosenfeld R. G. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab. 1994 Aug;79(2):428–434. doi: 10.1210/jcem.79.2.7519190. [DOI] [PubMed] [Google Scholar]
  26. Rajaram S., Baylink D. J., Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997 Dec;18(6):801–831. doi: 10.1210/edrv.18.6.0321. [DOI] [PubMed] [Google Scholar]
  27. Reeve J. G., Payne J. A., Bleehen N. M. Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours. Br J Cancer. 1990 May;61(5):727–731. doi: 10.1038/bjc.1990.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Renehan A. G., O'Dwyer S. T. Surveillance after colorectal cancer resection. Lancet. 2000 Mar 25;355(9209):1095–1096. doi: 10.1016/S0140-6736(05)72214-5. [DOI] [PubMed] [Google Scholar]
  29. Renehan A. G., Painter J. E., O'Halloran D., Atkin W. S., Potten C. S., O'Dwyer S. T., Shalet S. M. Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab. 2000 Sep;85(9):3402–3408. doi: 10.1210/jcem.85.9.6770. [DOI] [PubMed] [Google Scholar]
  30. Taylor A. M., Dunger D. B., Preece M. A., Holly J. M., Smith C. P., Wass J. A., Patel S., Tate V. E. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol (Oxf) 1990 Feb;32(2):229–239. doi: 10.1111/j.1365-2265.1990.tb00859.x. [DOI] [PubMed] [Google Scholar]
  31. Thissen J. P., Ketelslegers J. M., Underwood L. E. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994 Feb;15(1):80–101. doi: 10.1210/edrv-15-1-80. [DOI] [PubMed] [Google Scholar]
  32. Toogood A. A., Jones J., O'Neill P. A., Thorner M. O., Shalet S. M. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) 1998 May;48(5):569–576. doi: 10.1046/j.1365-2265.1998.00440.x. [DOI] [PubMed] [Google Scholar]
  33. Tricoli J. V., Rall L. B., Karakousis C. P., Herrera L., Petrelli N. J., Bell G. I., Shows T. B. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 1986 Dec;46(12 Pt 1):6169–6173. [PubMed] [Google Scholar]
  34. Turnbull R. B., Jr, Kyle K., Watson F. R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. doi: 10.1097/00000658-196709000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wang J. Y., Tang R., Chiang J. M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum. 1994 Mar;37(3):272–277. doi: 10.1007/BF02048166. [DOI] [PubMed] [Google Scholar]
  36. Wex H., Vorwerk P., Mohnike K., Bretschneider D., Kluba U., Aumann V., Blum W. F., Mittler U. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. Br J Cancer. 1998 Aug;78(4):515–520. doi: 10.1038/bjc.1998.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wolf R. F., Cohen A. M. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer. J Am Coll Surg. 1997 Jul;185(1):60–64. [PubMed] [Google Scholar]
  38. Yu H., Mistry J., Nicar M. J., Khosravi M. J., Diamandis A., van Doorn J., Juul A. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal. 1999;13(4):166–172. doi: 10.1002/(SICI)1098-2825(1999)13:4&#x0003c;166::AID-JCLA5&#x0003e;3.0.CO;2-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zumkeller W., Schwander J., Mitchell C. D., Morrell D. J., Schofield P. N., Preece M. A. Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour. Eur J Cancer. 1993;29A(14):1973–1977. doi: 10.1016/0959-8049(93)90455-o. [DOI] [PubMed] [Google Scholar]
  40. el Atiq F., Garrouste F., Remacle-Bonnet M., Sastre B., Pommier G. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int J Cancer. 1994 May 15;57(4):491–497. doi: 10.1002/ijc.2910570409. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES